Genpact Limited Financials
Genpact Limited (G) reported $5.1B in revenue for fiscal year 2025, up 6.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Genpact’s model converts service revenue into cash efficiently, with margin gains driven more by overhead discipline than gross-margin change.
From FY2023 to FY2025, gross margin moved only from35.1% to36.0% , so the later profit improvement looks more like cost discipline below gross profit than a structural change in revenue mix. That shows up in cash conversion: capex was just$78.2M against operating cash flow of$812.9M , leaving unusually little reinvestment drag for a business of this size.
Free cash flow quality strengthened in FY2025, with free cash flow margin at
Liquidity is still comfortable, but the current ratio fell from 2.2x to 1.7x as current liabilities rose faster than current assets, meaning some balance-sheet flexibility was used as the company expanded. At the same time, investing cash outflow widened to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Genpact Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Genpact Limited has an operating margin of 14.8%, meaning the company retains $15 of operating profit per $100 of revenue. This strong profitability earns a score of 83/100, reflecting efficient cost management and pricing power. This is up from 14.7% the prior year.
Genpact Limited's revenue grew 6.6% year-over-year to $5.1B, a solid pace of expansion. This earns a growth score of 56/100.
Genpact Limited carries a low D/E ratio of 0.46, meaning only $0.46 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 65/100, indicating a strong balance sheet with room for future borrowing.
Genpact Limited's current ratio of 1.66 indicates adequate short-term liquidity, earning a score of 47/100. The company can meet its near-term obligations, though with limited headroom.
Genpact Limited converts 14.5% of revenue into free cash flow ($734.7M). This strong cash generation earns a score of 74/100.
Genpact Limited earns a strong 21.7% return on equity (ROE), meaning it generates $22 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 88/100. This is up from 21.5% the prior year.
Genpact Limited scores 2.98, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Genpact Limited passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Genpact Limited generates $1.47 in operating cash flow ($812.9M OCF vs $552.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Genpact Limited earns $10.20 in operating income for every $1 of interest expense ($750.2M vs $73.5M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Genpact Limited generated $5.1B in revenue in fiscal year 2025. This represents an increase of 6.6% from the prior year.
Genpact Limited's EBITDA was $855.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.8% from the prior year.
Genpact Limited reported $552.5M in net income in fiscal year 2025. This represents an increase of 7.6% from the prior year.
Genpact Limited earned $3.13 per diluted share (EPS) in fiscal year 2025. This represents an increase of 9.8% from the prior year.
Cash & Balance Sheet
Genpact Limited generated $734.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 37.9% from the prior year.
Genpact Limited held $853.8M in cash against $1.2B in long-term debt as of fiscal year 2025.
Genpact Limited paid $0.68 per share in dividends in fiscal year 2025. This represents an increase of 11.5% from the prior year.
Margins & Returns
Genpact Limited's gross margin was 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.6 percentage points from the prior year.
Genpact Limited's operating margin was 14.8% in fiscal year 2025, reflecting core business profitability. That is unchanged from the prior year.
Genpact Limited's net profit margin was 10.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.1 percentage points from the prior year.
Genpact Limited's ROE was 21.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the prior year.
Capital Allocation
Genpact Limited invested $78.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 5.5% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
G Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.1B+6.6% | $4.8B+6.5% | $4.5B+2.4% | $4.4B+8.7% | $4.0B+8.4% | $3.7B+5.4% | $3.5B+17.3% | $3.0B+9.6% | $2.7B+6.5% | $2.6B+4.5% | $2.5B+8.0% | $2.3B+6.9% | $2.1B+12.1% | $1.9B+18.8% | $1.6B |
| Cost of Revenue | $3.3B | $3.2B+5.6% | $3.1B+5.9% | $2.9B+2.5% | $2.8B+9.4% | $2.6B+7.1% | $2.4B+5.4% | $2.3B+19.4% | $1.9B+14.3% | $1.7B+8.2% | $1.6B+4.1% | $1.5B+8.4% | $1.4B+4.4% | $1.3B+14.0% | $1.2B+15.2% | $1.0B |
| Gross Profit | $1.9B | $1.8B+8.3% | $1.7B+7.6% | $1.6B+2.2% | $1.5B+7.3% | $1.4B+10.9% | $1.3B+5.3% | $1.2B+13.6% | $1.1B+2.2% | $1.1B+3.8% | $1.0B+5.1% | $967.5M+7.3% | $901.4M+10.9% | $812.4M+9.2% | $744.2M+25.0% | $595.5M |
| SG&A Expenses | $1.1B | $1.0B+8.2% | $967.1M+5.9% | $913.1M-2.7% | $938.4M+8.4% | $865.7M+9.6% | $789.8M-0.6% | $794.9M+14.6% | $693.9M+0.6% | $689.5M+5.6% | $653.0M+7.4% | $608.1M+3.8% | $585.6M+20.8% | $484.8M+6.2% | $456.6M+27.6% | $358.0M |
| Operating Income | $778.6M | $750.2M+6.9% | $702.1M+11.3% | $630.9M+25.6% | $502.2M-1.3% | $509.0M+16.0% | $438.7M+2.2% | $429.4M+23.3% | $348.2M+5.1% | $331.3M-2.9% | $341.2M+2.1% | $334.2M+13.7% | $294.0M-5.0% | $309.5M+17.1% | $264.3M+22.2% | $216.2M |
| Interest Expense | $79.4M | $73.5M-7.5% | $79.5M+19.9% | $66.3M+14.1% | $58.1M-0.4% | $58.3M+3.7% | $56.2M+10.8% | $50.8M+4.7% | $48.5M+21.5% | $39.9M+70.4% | $23.4M-21.4% | $29.8M-11.8% | $33.8M-5.4% | $35.7M+27.0% | $28.1M+205.2% | $9.2M |
| Income Tax | $180.4M | $177.7M+8.9% | $163.2M+662.0% | -$29.0M-126.0% | $111.8M-1.6% | $113.7M+23.3% | $92.2M-2.5% | $94.5M+17.1% | $80.8M+35.2% | $59.7M-3.8% | $62.1M+0.3% | $61.9M+7.9% | $57.4M-19.2% | $71.1M-9.3% | $78.4M+11.0% | $70.7M |
| Net Income | $582.7M | $552.5M+7.6% | $513.7M-18.6% | $631.3M+78.6% | $353.4M-4.3% | $369.4M+19.8% | $308.3M+1.1% | $304.9M+8.1% | $282.0M+7.2% | $263.1M-2.4% | $269.7M+12.5% | $239.8M+24.9% | $192.0M-16.4% | $229.7M+28.9% | $178.2M-3.3% | $184.3M |
| EPS (Diluted) | — | $3.13+9.8% | $2.85-16.4% | $3.41+81.4% | $1.88-1.6% | $1.91+21.7% | $1.57+0.6% | $1.56+7.6% | $1.45+8.2% | $1.34+4.7% | $1.28+17.4% | $1.09+28.2% | $0.85-12.4% | $0.97+24.4% | $0.78-3.7% | $0.81 |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
G Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.8B+17.2% | $5.0B+3.8% | $4.8B+4.7% | $4.6B-7.8% | $5.0B+2.1% | $4.9B+9.4% | $4.5B+26.2% | $3.5B+2.3% | $3.4B+19.5% | $2.9B+3.3% | $2.8B+1.9% | $2.7B+2.0% | $2.7B+3.2% | $2.6B+8.4% | $2.4B |
| Current Assets | $2.7B+27.7% | $2.1B+10.0% | $1.9B+6.3% | $1.8B-7.4% | $1.9B+9.9% | $1.7B+12.7% | $1.6B+14.5% | $1.4B-5.5% | $1.4B+16.9% | $1.2B+2.7% | $1.2B+0.6% | $1.2B-6.9% | $1.3B+13.1% | $1.1B+14.6% | $985.1M |
| Cash & Equivalents | $853.8M+31.7% | $648.2M+11.1% | $583.7M-9.8% | $646.8M-28.1% | $899.5M+32.2% | $680.4M+45.7% | $467.1M+26.8% | $368.4M-27.0% | $504.5M+19.4% | $422.6M-6.3% | $450.9M-2.4% | $461.8M-19.2% | $571.3M+24.4% | $459.2M+12.6% | $408.0M |
| Accounts Receivable | $1.2B+3.5% | $1.2B+7.4% | $1.1B+12.2% | $994.8M+12.1% | $887.7M+0.8% | $881.0M-3.6% | $914.3M+18.1% | $774.2M+11.7% | $693.1M+12.6% | $615.3M+4.3% | $590.1M+12.2% | $525.8M+4.1% | $505.1M+11.8% | $452.0M+12.3% | $402.4M |
| Goodwill | $1.8B+6.7% | $1.7B-0.8% | $1.7B0.0% | $1.7B-2.7% | $1.7B+2.1% | $1.7B+7.7% | $1.6B+13.0% | $1.4B+4.2% | $1.3B+25.0% | $1.1B+3.0% | $1.0B-1.8% | $1.1B+10.8% | $953.8M-0.2% | $956.1M+3.3% | $925.3M |
| Total Liabilities | $3.3B+26.8% | $2.6B+1.6% | $2.6B-7.4% | $2.8B-10.2% | $3.1B+1.3% | $3.0B+9.9% | $2.8B+30.1% | $2.1B+5.2% | $2.0B+26.7% | $1.6B+7.1% | $1.5B+2.2% | $1.5B+6.7% | $1.4B-4.8% | $1.4B+48.2% | $967.7M |
| Current Liabilities | $1.6B+66.3% | $963.7M-26.9% | $1.3B+19.5% | $1.1B-15.7% | $1.3B+8.8% | $1.2B+32.1% | $910.2M-6.8% | $976.3M+16.4% | $838.8M+14.7% | $731.4M+23.0% | $594.5M-4.4% | $622.1M+34.7% | $461.7M-10.8% | $517.8M-21.8% | $661.8M |
| Long-Term Debt | $1.2B-2.4% | $1.2B+44.9% | $824.7M-34.0% | $1.2B-1.8% | $1.3B-2.7% | $1.3B-2.4% | $1.3B+37.3% | $975.6M-3.1% | $1.0B+44.2% | $698.2M-5.3% | $737.3M+13.6% | $649.3M-0.7% | $653.6M-0.5% | $656.9M+788.5% | $73.9M |
| Total Equity | $2.5B+6.7% | $2.4B+6.3% | $2.2B+23.1% | $1.8B-3.7% | $1.9B+3.4% | $1.8B+8.6% | $1.7B+20.3% | $1.4B-1.4% | $1.4B+10.7% | $1.3B-1.4% | $1.3B+1.5% | $1.3B-2.8% | $1.3B+13.2% | $1.2B-18.5% | $1.4B |
| Retained Earnings | $1.4B+12.4% | $1.2B+14.0% | $1.1B+39.1% | $780.0M+6.5% | $732.5M-1.2% | $741.7M+14.3% | $648.7M+47.9% | $438.5M+23.2% | $356.0M-0.6% | $358.1M-13.0% | $411.5M+3.2% | $398.7M-22.1% | $511.7M+81.5% | $282.0M-53.4% | $605.4M |
Not reported in any period shown, so not listed: Inventory.
G Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $644.0M | $812.9M+32.1% | $615.4M+25.4% | $490.8M+10.6% | $443.7M-36.1% | $694.3M+18.8% | $584.3M+36.6% | $427.9M+26.0% | $339.5M-5.4% | $359.1M+3.8% | $345.8M+5.6% | $327.4M+20.5% | $271.8M-12.8% | $311.6M+0.3% | $310.7M+16.5% | $266.6M |
| Capital Expenditures | $71.9M | $78.2M-5.5% | $82.8M+49.3% | $55.4M+9.5% | $50.6M-5.1% | $53.3M-24.0% | $70.2M-6.3% | $74.9M-11.8% | $85.0M+48.5% | $57.2M-30.1% | $81.9M+31.8% | $62.2M-0.6% | $62.6M+28.0% | $48.9M-41.3% | $83.3M+132.9% | $35.8M |
| Free Cash Flow | $572.1M | $734.7M+37.9% | $532.7M+22.3% | $435.4M+10.8% | $393.1M-38.7% | $640.9M+24.7% | $514.1M+45.7% | $353.0M+38.7% | $254.5M-15.7% | $301.8M+14.4% | $263.8M-0.5% | $265.3M+26.8% | $209.3M-20.3% | $262.7M+15.6% | $227.3M-1.5% | $230.8M |
| Investing Cash Flow | -$91.3M | -$495.5M-367.6% | -$106.0M-34.2% | -$78.9M-115.7% | -$36.6M+70.2% | -$122.7M+53.9% | -$266.4M+25.4% | -$357.1M-29.4% | -$276.1M+23.7% | -$362.0M-187.8% | -$125.8M | N/A | -$192.8M-145.8% | -$78.4M+50.1% | -$157.3M+70.6% | -$535.1M |
| Financing Cash Flow | -$645.4M | -$106.8M+74.9% | -$424.8M+12.0% | -$483.0M+15.5% | -$571.4M-71.7% | -$332.9M-261.8% | -$92.0M-332.1% | $39.6M+129.3% | -$135.2M-386.5% | $47.2M+120.3% | -$232.8M | N/A | -$177.4M-171.5% | -$65.3M+38.4% | -$106.1M-132.5% | $326.1M |
| Dividends Paid | $121.7M | $117.7M+8.6% | $108.5M+8.5% | $100.0M+8.9% | $91.8M+14.1% | $80.5M+8.4% | $74.2M+14.8% | $64.7M+13.3% | $57.1M+22.3% | $46.7M | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | $252.7M+12.0% | $225.5M+5.3% | $214.1M-28.2% | $298.2M+117.5% | $137.1M+356.8% | $30.0M-80.5% | $154.2M-29.9% | $219.8M-36.3% | $345.2M+52.1% | $226.9M-25.0% | $302.6M | N/A | N/A | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
G Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.0%+0.6pp | 35.4%+0.4pp | 35.1%-0.1pp | 35.1%-0.5pp | 35.6%+0.8pp | 34.8%0.0pp | 34.8%-1.1pp | 36.0%-2.6pp | 38.6%-1.0pp | 39.5%+0.2pp | 39.3%-0.2pp | 39.5%+1.4pp | 38.1%-1.0pp | 39.1%+1.9pp | 37.2% |
| Operating Margin | 14.8%0.0pp | 14.7%+0.6pp | 14.1%+2.6pp | 11.5%-1.2pp | 12.7%+0.8pp | 11.8%-0.4pp | 12.2%+0.6pp | 11.6%-0.5pp | 12.1%-1.2pp | 13.3%-0.3pp | 13.6%+0.7pp | 12.9%-1.6pp | 14.5%+0.6pp | 13.9%+0.4pp | 13.5% |
| Net Margin | 10.9%+0.1pp | 10.8%-3.3pp | 14.1%+6.0pp | 8.1%-1.1pp | 9.2%+0.9pp | 8.3%-0.4pp | 8.7%-0.7pp | 9.4%-0.2pp | 9.6%-0.9pp | 10.5%+0.7pp | 9.7%+1.3pp | 8.4%-2.4pp | 10.8%+1.4pp | 9.4%-2.1pp | 11.5% |
| Return on Equity | 21.7%+0.2pp | 21.5%-6.6pp | 28.1%+8.7pp | 19.4%-0.1pp | 19.5%+2.7pp | 16.8%-1.2pp | 18.1%-2.0pp | 20.1%+1.6pp | 18.5%-2.5pp | 21.0%+2.6pp | 18.4%+3.5pp | 14.9%-2.4pp | 17.4%+2.1pp | 15.3%+2.4pp | 12.9% |
| Return on Assets | 9.5%-0.8pp | 10.3%-2.8pp | 13.1%+5.4pp | 7.7%+0.3pp | 7.4%+1.1pp | 6.3%-0.5pp | 6.8%-1.1pp | 8.0%+0.4pp | 7.6%-1.7pp | 9.3%+0.8pp | 8.6%+1.6pp | 7.0%-1.5pp | 8.5%+1.7pp | 6.8%-0.8pp | 7.7% |
| Current Ratio | 1.66-0.5x | 2.16+0.7x | 1.44-0.2x | 1.61+0.1x | 1.470.0x | 1.45-0.3x | 1.70+0.3x | 1.39-0.3x | 1.710.0x | 1.68-0.3x | 2.01+0.1x | 1.91-0.9x | 2.76+0.6x | 2.18+0.7x | 1.49 |
| Debt-to-Equity | 0.460.0x | 0.50+0.1x | 0.37-0.3x | 0.680.0x | 0.670.0x | 0.71-0.1x | 0.79+0.1x | 0.690.0x | 0.71+0.2x | 0.540.0x | 0.57+0.1x | 0.510.0x | 0.49-0.1x | 0.56+0.5x | 0.05 |
| FCF Margin | 14.5%+3.3pp | 11.2%+1.4pp | 9.7%+0.7pp | 9.0%-6.9pp | 15.9%+2.1pp | 13.9%+3.8pp | 10.0%+1.6pp | 8.5%-2.5pp | 11.0%+0.8pp | 10.3%-0.5pp | 10.8%+1.6pp | 9.2%-3.1pp | 12.3%+0.4pp | 11.9%-2.5pp | 14.4% |
Similar Companies
Where Genpact Limited Ranks
Frequently Asked Questions
What is Genpact Limited's annual revenue?
Genpact Limited (G) reported $5.1B in total revenue for fiscal year 2025. This represents a 6.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Genpact Limited's revenue growing?
Genpact Limited (G) revenue grew by 6.6% year-over-year, from $4.8B to $5.1B in fiscal year 2025.
Is Genpact Limited profitable?
Yes, Genpact Limited (G) reported a net income of $552.5M in fiscal year 2025, with a net profit margin of 10.9%.
What is Genpact Limited's EBITDA?
Genpact Limited (G) had EBITDA of $855.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Genpact Limited have?
As of fiscal year 2025, Genpact Limited (G) had $853.8M in cash and equivalents against $1.2B in long-term debt.
What is Genpact Limited's gross margin?
Genpact Limited (G) had a gross margin of 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Genpact Limited's operating margin?
Genpact Limited (G) had an operating margin of 14.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Genpact Limited's net profit margin?
Genpact Limited (G) had a net profit margin of 10.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Genpact Limited pay dividends?
Yes, Genpact Limited (G) paid $0.68 per share in dividends during fiscal year 2025.
What is Genpact Limited's return on equity (ROE)?
Genpact Limited (G) has a return on equity of 21.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Genpact Limited's free cash flow?
Genpact Limited (G) generated $734.7M in free cash flow during fiscal year 2025. This represents a 37.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Genpact Limited's operating cash flow?
Genpact Limited (G) generated $812.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Genpact Limited's total assets?
Genpact Limited (G) had $5.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Genpact Limited's capital expenditures?
Genpact Limited (G) invested $78.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Genpact Limited's current ratio?
Genpact Limited (G) had a current ratio of 1.66 as of fiscal year 2025, which is generally considered healthy.
What is Genpact Limited's debt-to-equity ratio?
Genpact Limited (G) had a debt-to-equity ratio of 0.46 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Genpact Limited's return on assets (ROA)?
Genpact Limited (G) had a return on assets of 9.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Genpact Limited's Altman Z-Score?
Genpact Limited (G) has an Altman Z-Score of 2.98, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Genpact Limited's Piotroski F-Score?
Genpact Limited (G) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Genpact Limited's earnings high quality?
Genpact Limited (G) has an earnings quality ratio of 1.47x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Genpact Limited cover its interest payments?
Genpact Limited (G) has an interest coverage ratio of 10.20x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Genpact Limited?
Genpact Limited (G) scores 69 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.